scholarly journals The first oxazoline adduct of Zn(acac)2: bis(acetylacetonato-j2O,O0)(2-phenyl-2- oxazoline-jN)zinc(II)

2021 ◽  
Author(s):  
Ignacio del Rio ◽  
Robert A Gossage

The title material, [Zn(C(5)H(7)O(2))(2)(C(9)H(9)NO)], was synthesized by the treatment of bis-(acetyl-acetonato)zinc(II) monohydrate with 2-phenyl-2-oxazoline. The Zn atom is coordinated by two chelating acetyl-acetonate groups and one oxazoline ligand in the apical position of a slightly distorted square-pyramidal metal-ligand geometry.

2021 ◽  
Author(s):  
Ignacio del Rio ◽  
Robert A Gossage

The title material, [Zn(C(5)H(7)O(2))(2)(C(9)H(9)NO)], was synthesized by the treatment of bis-(acetyl-acetonato)zinc(II) monohydrate with 2-phenyl-2-oxazoline. The Zn atom is coordinated by two chelating acetyl-acetonate groups and one oxazoline ligand in the apical position of a slightly distorted square-pyramidal metal-ligand geometry.


2020 ◽  
Vol 61 (12) ◽  
pp. 1876-1887
Author(s):  
T. V. Berestova ◽  
K. N. Nosenko ◽  
O. V. Lusina ◽  
L. G. Kuzina ◽  
E. I. Kulish ◽  
...  

2003 ◽  
Vol 68 (9) ◽  
pp. 1647-1662 ◽  
Author(s):  
Valeria Amendola ◽  
Massimo Boiocchi ◽  
Yuri Diaz Fernandez ◽  
Carlo Mangano ◽  
Piersandro Pallavicini

The bis-bidentate ligand R,S-1,2-diphenyl-N,N'-bis(2-quinolinemethylidene)ethane-1,2-diamine (ligand 4), containing two (iminomethyl)quinoline moieties separated by a cis-1,2-diphenylethylene spacer, forms stable complexes with both CuI and CuII. With CuII, the monomeric 1:1 complex [CuII(4)]2+ is obtained both in CH3CN and CH2Cl2. With CuI and overall 1:1 metal/ligand molar ratio, an equilibrium mixture is obtained in CH3CN, consisting of [CuI(4)2]+, [CuI2(4)2]2+ and [CuI2(4)(CH3CN)4]2+. The preponderant species is the two-metal one-ligand "open" complex [CuI2(4)(CH3CN)4]2+, in which each Cu+ cation is coordinated in a tetrahedral fashion by one (iminomethyl)quinoline unit and by two CH3CN molecules. Precipitation from the equilibrium mixture yields only crystals of [CuI2(4)(CH3CN)4](ClO4)2·2CH3CN, whose crystal and molecular structures have been determined. On the other hand, in the poorly coordinating CH2Cl2 solvent, only the dimeric helical [CuI2(4)2]2+ complex is obtained, when the overall metal/ligand 1:1 molar ratio is chosen. Addition of large quantities of acetonitrile to solutions of [CuI2(4)2]2+ in dichlorometane results in the formation of [CuI2(4)(CH3CN)4]2+, i.e. in the solvent-driven disassembling of the CuI helicate. While electrochemistry in CH3CN is poorly defined due to the presence of more than one CuI species, cyclic voltammetry experiments carried out in CH2Cl2 revealed a well defined behavior, with irreversible oxidation of [CuI2(4)2]2+ and irreversible reduction of [CuII(4)]2+ taking place at separate potentials (∆E ≈ 700 mV). Irreversibility and separation of the redox events are due to the self-assembling and disassembling processes following the reduction and oxidation, respectively.


Molecules ◽  
2021 ◽  
Vol 26 (12) ◽  
pp. 3598
Author(s):  
Nirmal K. Shee ◽  
Hee-Joon Kim

A series of porphyrin triads (1–6), based on the reaction of trans-dihydroxo-[5,15-bis(3-pyridyl)-10,20-bis(phenyl)porphyrinato]tin(IV) (SnP) with six different phenoxy Zn(II)-porphyrins (ZnLn), was synthesized. The cooperative metal–ligand coordination of 3-pyridyl nitrogens in the SnP with the phenoxy Zn(II)-porphyrins, followed by the self-assembly process, leads to the formation of nanostructures. The red-shifts and remarkable broadening of the absorption bands in the UV–vis spectra for the triads in CHCl3 indicate that nanoaggregates may be produced in the self-assembly process of these triads. The emission intensities of the triads were also significantly reduced due to the aggregation. Microscopic analyses of the nanostructures of the triads reveal differences due to the different substituents on the axial Zn(II)-porphyrin moieties. All these nanomaterials exhibited efficient photocatalytic performances in the degradation of rhodamine B (RhB) dye under visible light irradiation, and the degradation efficiencies of RhB in aqueous solution were observed to be 72~95% within 4 h. In addition, the efficiency of the catalyst was not impaired, showing excellent recyclability even after being applied for the degradation of RhB in up to five cycles.


ACS Catalysis ◽  
2021 ◽  
pp. 9043-9051
Author(s):  
Matthew R. Elsby ◽  
Mina Son ◽  
Changjin Oh ◽  
Jessica Martin ◽  
Mu-Hyun Baik ◽  
...  

ACS Catalysis ◽  
2021 ◽  
pp. 7553-7567
Author(s):  
María Galiana-Cameo ◽  
Asier Urriolabeitia ◽  
Eduardo Barrenas ◽  
Vincenzo Passarelli ◽  
Jesús J. Pérez-Torrente ◽  
...  
Keyword(s):  

Author(s):  
Huijie Pan ◽  
Gangfeng Huang ◽  
Matthew Wodrich ◽  
Farzaneh Fadaei Tirani ◽  
Kenichi Ataka ◽  
...  

2020 ◽  
Vol 5 (4) ◽  
Author(s):  
Gabrielle Drevet ◽  
Jean-Michel Maury ◽  
Naoual Bakrin ◽  
François Tronc

AbstractObjectivesMalignant pleural effusion (MPE) is a devastating evolution of several malignancies. Pressurized intrathoracic aerosol chemotherapy (PITAC) might be a novel therapy option in MPE.MethodsPITAC is considered for patients with MPE with a performance status <2 and without other metastatic sites. General anesthesia is administered and a double-lumen bronchial tube is inserted. The patient is placed in a lateral decubitus position, and the operation is performed after ipsilateral lung exclusion. Two 12-mm balloon trocars are inserted—one in the seventh intercostal space in the mid-axillary line and one in the fifth intercostal space in the anterior axillary line. Extent of pleural disease and volume of MPE are documented. MPE is removed and parietal pleural biopsy are performed. An intrathoracic pressure of 12 mmHg CO2 is established, and a combination of Cisplatin (10.5 mg/m2 in a total volume of 150 cc NaCl 0.9%) and Doxorubicin (2.1 mg/m2 in a total volume of 50 cc NaCl 0.9%) are aerosolized via nebulizer in the pleural cavity. Vital signs and nebulization are remote-controlled. After 30 min, the remaining toxic aerosol is exhausted using a closed surgical smoke evacuation system. A 24Fr chest tube is inserted in postero-apical position with continuous negative pressure of 20 cm H2O. When needed, PITAC may be repeated every six weeks in alternate with systemic chemotherapy.ResultsIn our hands, the technique above has shown to be feasible and safe.ConclusionsFurther studies are needed to assess the potential symptomatic and oncological benefits of PITAC in MPE.


Sign in / Sign up

Export Citation Format

Share Document